Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 56Unknown 25Recruiting 13Terminated 10Withdrawn 4Active not recruiting 3Not yet recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Genitourinary 1CNS 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Pain, Postoperative 1Brain Neoplasms 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Bupivacaine × Clear all
NCT03177252 2020-10-22

Scalp block

Washington University School of Medicine

Phase 1 Withdrawn
CNS

Brain Neoplasms

NCT02822196 2020-09-16

Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies

The University of Texas Health Science Center, Houston

Phase 4 Withdrawn
Breast

Breast Neoplasms, Pain, Postoperative

NCT03393117 2020-07-22

Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction

Case Comprehensive Cancer Center

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT01565512 2015-03-05

Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort

Columbia University

Phase 1/2 Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡